Sunshine Lake Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,404	1,674	923.54	1,131	2,045
Trading Asset Securities	3.84	-	290	-	-
Cash & Short-Term Investments	1,408	1,674	1,214	1,131	2,045
Cash Growth	-15.93%	37.98%	7.29%	-44.69%	-26.42%
Accounts Receivable	2,104	2,073	1,006	479.04	460.51
Other Receivables	153.65	40.19	31.1	67.75	139.25
Receivables	2,257	2,113	1,037	546.79	599.76
Inventory	645.93	409.05	315.03	279.7	378.27
Restricted Cash	395.61	1,567	76.78	91.99	221.19
Other Current Assets	326.91	289.5	2,372	7.78	19.93
Total Current Assets	5,033	6,053	5,014	2,057	3,264
Property, Plant & Equipment	3,964	3,740	3,519	3,217	2,836
Long-Term Investments	42.53	32.16	-	1,790	-
Goodwill	-	-	-	75.9	75.9
Other Intangible Assets	1,214	1,470	2,921	2,071	1,536
Long-Term Deferred Tax Assets	236.01	237.69	140.61	65.32	40.65
Long-Term Deferred Charges	1,289	1,095	-	1,201	1,173
Other Long-Term Assets	650.08	115.38	295.76	64.83	635.32
Total Assets	12,429	12,744	11,890	10,542	9,561
Accounts Payable	192.55	200.52	178.61	193.47	244.94
Accrued Expenses	774.67	1,397	1,342	480.34	786.68
Short-Term Debt	-	-	-	-	345.99
Current Portion of Long-Term Debt	1,174	2,165	3,055	48.48	2,475
Current Portion of Leases	161.32	154.44	75.44	-	-
Current Income Taxes Payable	0.23	146.21	8.67	198.63	20.44
Current Unearned Revenue	37.63	109.64	83.58	79.28	60.53
Other Current Liabilities	500.43	158.48	197.86	237.87	227.82
Total Current Liabilities	2,841	4,332	4,941	1,238	4,161
Long-Term Debt	747.27	254	629.03	3,145	189.85
Long-Term Leases	152.54	35.45	62.5	-	-
Long-Term Unearned Revenue	180.68	187.15	187.49	137.73	106.54
Total Liabilities	3,921	4,809	5,820	4,521	4,458
Common Stock	879.97	879.97	879.97	879.97	879.97
Retained Earnings	4,870	4,387	2,395	2,318	2,906
Comprehensive Income & Other	2,758	2,668	2,610	2,610	1,106
Total Common Equity	8,508	7,936	5,885	5,808	4,891
Minority Interest	-	-	185.12	212.48	212.56
Shareholders' Equity	8,508	7,936	6,070	6,021	5,104
Total Liabilities & Equity	12,429	12,744	11,890	10,542	9,561
Total Debt	2,235	2,609	3,822	3,194	3,011
Net Cash (Debt)	-827.22	-934.92	-2,608	-2,062	-965.69
Net Cash Per Share	-3.57	-4.03	-11.24	-8.89	-3.31
Filing Date Shares Outstanding	879.97	879.97	879.97	879.97	879.97
Total Common Shares Outstanding	879.97	879.97	879.97	879.97	879.97
Working Capital	2,193	1,721	73.24	819.31	-897.1
Book Value Per Share	9.67	9.02	6.69	6.60	5.56
Tangible Book Value	7,294	6,465	2,964	3,662	3,279
Tangible Book Value Per Share	8.29	7.35	3.37	4.16	3.73
Machinery	3,660	3,448	3,021	2,680	1,601
Construction In Progress	826.56	638.2	675.45	567.94	1,187

Source: S&P Global Market Intelligence. Standard template. Financial Sources.